DETERMINATION OF SUNSET YELLOW AS A SYNTHETIC FOOD COLORANT IN CONFECTIONERY PRODUCTS CONSUMED IN KATSINA METROPOLIS (NIGERIA) USING UV-VIS SPECTROPHOTOMETER
DOI:
https://doi.org/10.33003/fjs-2021-0501-576Keywords:
Sunset yellow, Food safety, Confectionaries, UV-Visible SpectrophotometerAbstract
The use of Sunset yellow as food colorants in non-alcoholic drinks, beverages and confectionery is rising despite their problems upon consumption by humans. It is therefore, necessary to constantly monitor the concentrations of these dyes in our foods, beverages and confectionery because of their health-related issues that include hyperactivity in children and immune system compromise. For these reasons, the concentration of sunset yellow used as colorants was determined in ten different brands of confectionaries using the spectrophotometric method of analysis. A cross-sectional primary data was obtained through experimental procedures in ten different samples of confectionary products procured (Central Market Katsina, Nigeria). The results shown that the concentration for the two samples; E and I are 52.311±0.178 mg/L and 87.887±0.018 mg/L respectively were found to be above the acceptable permissible limit of 50mg/L, while for the remaining eight samples; A, B, C, D, F, G, H, and J are, 46.523±0.116 mg/L, 49.364±0.418 mg/L, 41.924±0.029 mg/L, 27.853±0.029 mg/L, 33.045±0.018 mg/L, 29.515±0.028 mg/L, 34.250±0.019 mg/L and 33.295±0.018 mg/L respectively are within the acceptable permissible limit of 50 mg/L in accordance to Regulation (EC) No. 1333/2008 of the European Parliament and council establishing a Union list of food additives. Therefore, the results justify the safe consumption of samples A, B, C, D, F, G, H and J but samples E and I are not safe for consumption due to their concentration levels found above 50 mg/L.
References
Addiss D (2011). Global Alliance to Eliminate Lymphatic Filariasis. The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of LF elimination and its integration with the control of other neglected tropical diseases. Parasite and Vectors 3: 100.
Akogun, O.B., Akogun, M.K., Apake, E. and Kale, O.O. Rapid community identification, pain and distress associated with lymphoedema and adenolymphangitis due to lymphatic filariasis in resource-limited communities of North-eastern Nigeria. Acta Tropica. 2011; 120(Supplement 1): S62–S8.
Badaki, J.A. (2010).Parasitological and social aspects of lymphatic filariasis in Taraba state. PhD thesis. University of Jos, Nigeria, Department of Zoology. pp. 1-150
Cantey, P.T. (2010). Increase compliance with mass drug administration programme for lymphatic filariasis in India through education and lymphedema management programmes. Plos Neglected Tropical Diseases, 4:e728 (doi: 10.1371/0000728).
Cheesbrough M. 2010. District Laboratory Practice in Tropical Countries (2nded.). Cambridge University Press, pp. 280-285.
Eigege, A., Kal, A., Sallau, A. and Umaru J. (2013). Long-lasting Insecticidal Nets are synergistic with Mass Drug Administration for interruption of Lymphatic Filariasis Transmission in Nigeria. Plos Neglected Tropical Disease 7(10) e2508.
Elkanah, O. S. (2006). A study on the epidemiology, Community perception and diagnosis of Bancroftian Filariasis in Lau L.G.A. Taraba State. M.Sc. University of Jos, Nigeria, Department of Zoology. pp 1-120.
Federal Ministry of Health (FMOH) (2013). Guidelines for Malaria-lymphatic filariasis Co-implementation in Nigeria. Department of Public Health. https://www.cartercenter.org/resources/pdfs/news/health_publications/malaria/guidelines-malaria-lf-co-implementation-nigeria-9-13.pdf
Hotez, P.J., Asojo O.A., and Adesina A.M. (2012). Nigeria: “Ground Zero†for the High Prevalence Neglected Tropical Diseases. PLoS Neglected Tropical Disease. 6: 1600:10.1371.
McCarthy, J.S., Lustigman, S., Yang, J., Barakat, R.M., GarcÃa, H.H., Sripa, B., Willingham, A.L., Prichard, R.K. and Basáñez, M. (2012). A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis., 6: e1601
Okoro, N., Nwali, U. N., Nnamdi, O. A., Innocent, O. C., Somadina, O. C. and Shedrack, E. O. (2014). The prevalence and Distribution of Human Onchocerciasis in two senatorial District in Ebonyi State. Journal of Science and Education, 2 (2): 39-44.
Stanton, M.C., Yamauchi, M., Mkwanda, S.Z., Ndhlovu, P., Matipula, D.E. and Mackenzie, C. (2017) Measuring the physical and economic impact of filarial lymphoedema in Chikwawa district, Malawi: a case-control study. Infection Disease of Poverty; 6(28):67–74.
Thiele, E. A., Cama, V. A., Lakwo, T., Mekasha, S., Abanyie, F., Sleshi, M., Kebede, A. and Cantey, P. T. (2016). Detection of Onchocerca volvulus in skin snips by microscopy and real-time polymerase chain reaction: Implications for monitoring and evaluation activities. American Journal of Tropical Medicine and Hygiene, 94(4), 906–911.
Tyrell. E. (2013). Socioeconomic burden of lymphatic filariasis in Georgetown, Guyana. Trop Med International Health: 18(2):152–8.
World Health Organization (2010). Global Programme to Eliminate Lymphatic Filariasis Progress Report 2000-2009 and Strategic Plan 2010-2020, WHO Press, Geneva 27, Switzerland.
Weil, G.J., Curtis, K.C., Fakoli, L., Fischer, K., Gankpala, L. and Lammie, P.J. (2013). Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am Journal of Tropical Medicine and Hygiene, 89(1):11–5.
World Health Organization. (2011). Global programme to eliminate lymphatic filariasis: progress report. Weekly Epidemiology Record 87: 346–356
World Health Organization. (2013). Lymphatic filariasis: a handbook of practical entomology for Global Programme to eliminate lymphatic filariasis: progress report. Weekly Epidemiology, Record, 87: 346–356
Yahathugoda, C., Supali, T., Rao, R., Djuardi, T., Stefani, D., Pical, F., Fischer, P., Lloyd, M., Premaratne, P., Weerasooriya, M. and Weil, G. (2015). A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration. Parasites & vectors. 8. 369. 10.1186/s13071-015-0979-y.
Published
How to Cite
Issue
Section
FUDMA Journal of Sciences